FGFR2-BICC1/BaF3
CBP73268
| I. Background | |
|
FGFR2-BICC1 是肝内胆管癌中最常见的 FGFR2 融合亚型,占所有 FGFR2 融合病例的 30%左右,由 FGFR2 的激酶结构域与 BICC1 基因的二聚化结构域顺利获得染色体重排拼接而 成。融合后蛋白无需依赖配体结合,即可自主发生二聚化并持续自磷酸化,不间断激活下 游 RAS/MAPK、PI3K/AKT 等促癌通路,驱动肿瘤细胞无限增殖。 |
|
| II. Description | |
|
FGFR2-BICC1 BaF3 药靶细胞,顺利获得转导融合状态的 FGFR2-BICC1 基因 到 BaF3 细胞系中,稳定表达人融合形态下的 FGFR2-BICC1 基因。
|
|
| III. Introduction | |
|
Cell Line Name: |
FGFR2-BICC1/BaF3 |
|
Host Cell: |
Ba/F3 |
| Stability: | 32 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
|
Application: |
Anti-proliferation assay and PD assay |
|
Freeze Medium: |
90% FBS+10% DMSO |
|
Complete Culture Medium: |
RPMI-1640 + 10% FBS |
|
Mycoplasma Status: |
Negative |
| IV. Representative Data | |
|
1.WB of FGFR2-BICC1/BaF3
|
|
|
2.Sanger of FGFR2-BICC1/BaF3
|
|
|
3. Anti-proliferation assay Figure 4. CTG Proliferation Assay of FGFR2-BICC1 BaF3 (C8). |
|